AS
Altshuler Shaham Portfolio holdings
AUM
$3.14B
1-Year Return
24.55%
This Quarter Return
+7.83%
1 Year Return
+24.55%
3 Year Return
+51.84%
5 Year Return
+71.45%
10 Year Return
–
AUM
$2.5B
AUM Growth
-$1.57B
(-39%)
Cap. Flow
-$1.79B
Cap. Flow
% of AUM
-71.81%
Top 10 Holdings %
Top 10 Hldgs %
88.46%
Holding
621
New
174
Increased
68
Reduced
174
Closed
178
Top Buys
| 1 |
Citigroup
C
|
+$175M |
| 2 |
Bank of America
BAC
|
+$172M |
| 3 |
Wells Fargo
WFC
|
+$171M |
| 4 |
JPMorgan Chase
JPM
|
+$157M |
| 5 |
ICL Group
ICL
|
+$132M |
Top Sells
| 1 |
Global X Copper Miners ETF NEW
COPX
|
+$654M |
| 2 |
iShares MSCI South Korea ETF
EWY
|
+$450M |
| 3 |
Caterpillar
CAT
|
+$422M |
| 4 |
Deere & Co
DE
|
+$421M |
| 5 |
Home Depot
HD
|
+$385M |
Sector Composition
| 1 | Financials | 42.44% |
| 2 | Materials | 18.49% |
| 3 | Technology | 15.23% |
| 4 | Industrials | 13.02% |
| 5 | Utilities | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Factset
FDS
$13.7B
| $30.5K | ﹤0.01% |
76
-71
| -48% | -$28.5K |
|
302
Adeia
ADEA
$1.65B
| $30.1K | ﹤0.01% |
+3,179
| New | +$30.1K |
|
303
Hackett Group
HCKT
$563M
| $30K | ﹤0.01% |
1,473
-209
| -12% | -$4.26K |
|
304
Inspire Medical Systems
INSP
$2.33B
| $29.2K | ﹤0.01% |
+116
| New | +$29.2K |
|
|
FZT
305
DELISTED
FAST Acquisition Corp. II
FZT
| $28.9K | ﹤0.01% |
+43,125
| New | +$28.9K |
|
306
Intrepid Potash
IPI
$392M
| $28.9K | ﹤0.01% |
1,000
| – | – |
|
307
Collegium Pharmaceutical
COLL
$1.19B
| $28.2K | ﹤0.01% |
+1,215
| New | +$28.2K |
|
308
Globus Medical
GMED
$7.89B
| $28.1K | ﹤0.01% |
+379
| New | +$28.1K |
|
309
Quest Diagnostics
DGX
$20.1B
| $27.8K | ﹤0.01% |
178
-31
| -15% | -$4.85K |
|
310
Abbott
ABT
$225B
| $27.8K | ﹤0.01% |
+253
| New | +$27.8K |
|
311
FibroGen
FGEN
$46.5M
| $27.6K | ﹤0.01% |
+69
| New | +$27.6K |
|
312
Bruker
BRKR
$4.63B
| $27.4K | ﹤0.01% |
+401
| New | +$27.4K |
|
313
Medpace
MEDP
$13.4B
| $27.4K | ﹤0.01% |
+129
| New | +$27.4K |
|
314
Prestige Consumer Healthcare
PBH
$3.2B
| $27.3K | ﹤0.01% |
+436
| New | +$27.3K |
|
315
The Ensign Group
ENSG
$9.59B
| $27.2K | ﹤0.01% |
288
-19
| -6% | -$1.8K |
|
316
Pfizer
PFE
$140B
| $27.1K | ﹤0.01% |
529
-10,130
| -95% | -$519K |
|
317
Qiagen
QGEN
$9.98B
| $27.1K | ﹤0.01% |
512
-34
| -6% | -$1.8K |
|
318
Boston Scientific
BSX
$156B
| $26.9K | ﹤0.01% |
582
-61
| -9% | -$2.82K |
|
319
Penumbra
PEN
$10.6B
| $26.9K | ﹤0.01% |
+121
| New | +$26.9K |
|
320
Amicus Therapeutics
FOLD
$2.45B
| $26.6K | ﹤0.01% |
2,181
-140
| -6% | -$1.71K |
|
321
Moderna
MRNA
$9.46B
| $26.6K | ﹤0.01% |
148
-758
| -84% | -$136K |
|
|
SILK
322
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $26.5K | ﹤0.01% |
502
-143
| -22% | -$7.56K |
|
323
BioMarin Pharmaceuticals
BMRN
$10.5B
| $26.5K | ﹤0.01% |
256
-36
| -12% | -$3.73K |
|
324
Merit Medical Systems
MMSI
$5.26B
| $26.4K | ﹤0.01% |
+374
| New | +$26.4K |
|
325
Ionis Pharmaceuticals
IONS
$10.2B
| $26.3K | ﹤0.01% |
695
-690
| -50% | -$26.1K |
|